Literature DB >> 17594788

Cardiac troponin I concentrations in people presenting with diabetic ketoacidosis.

J Geddes1, K A Deans, A Cormack, D Motherwell, K Paterson, D St J O'Reilly, B M Fisher.   

Abstract

BACKGROUND: Elevated troponin concentrations may be observed in a wide spectrum of medical disorders in people without evidence of overt ischaemic heart disease. The prospective relationship between serum cardiac troponin I (cTnI) and diabetic ketoacidosis (DKA) has not been examined in adults.
METHODS: Forty patients (14 male and 26 female) with type 1 diabetes were recruited. cTnI, creatine kinase (CK), cystatin C and beta-hydroxybutyrate were measured on admission and at 24, 48 and 72 h post-admission. Daily electrocardiographs were also performed.
RESULTS: Four out of forty subjects presenting with DKA had an increase in cTnI (median (SD) 0.06 (0.31) microg/L). One of the subjects had multiple possible reasons for the elevated cTnI concentration. However, the other three subjects had no obvious precipitating factors. This cohort underwent echocardiography and thallium-201 scintigraphy, which revealed no abnormalities.
CONCLUSIONS: Minor troponin elevations appear to occur in a small number of subjects with type 1 diabetes presenting with DKA. The clinical relevance of this at this stage remains unknown and further large-scale studies are suggested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594788     DOI: 10.1258/000456307780945750

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome.

Authors:  Anthony Eubanks; Farhan Raza; Mohamad Alkhouli; April N Glenn; Carol Homko; Abul Kashem; Alfred Bove
Journal:  Cardiovasc Diabetol       Date:  2012-12-27       Impact factor: 9.951

2.  Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage.

Authors:  Vasundhara Kain; Sandeep Kumar; Amrutesh S Puranik; Sandhya L Sitasawad
Journal:  Cardiovasc Diabetol       Date:  2010-12-01       Impact factor: 9.951

3.  Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy.

Authors:  Guoguang Wang; Wei Li; Xiaohua Lu; Xue Zhao
Journal:  Heart Int       Date:  2011-11-22

4.  A Case of Pseudoinfarction Pattern in Diabetic Ketoacidosis: A Diagnostic and Therapeutic Dilemma.

Authors:  Eliza Sharma; Suyash Dahal; Pratibha Sharma; Dipesh Kc Ghimire; Sumit Dahal
Journal:  Cardiol Res       Date:  2018-08-10

5.  Myocardial injury in a pediatric patient with diabetic ketoacidosis: A case report.

Authors:  Houn Joe Shim; Byung Min Yoo; Seon Mi Jin; Min Jae Kang
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

6.  Elevated Troponin I Levels in Diabetic Ketoacidosis Without Obstructive Coronary Artery Disease.

Authors:  Ajaydas T Manikkan
Journal:  J Endocr Soc       Date:  2018-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.